 This is a prospective, single center, randomized, double-blinded, placebo-controlled, exploratory phase I clinical trial in healthy male subjects to investigate the safety and tolerability of the cytokine based gel APOSECTM. The proof of safety and tolerability of APOSECTM is the primary objective. The secondary objective is to measure the extent of wound healing of APOSECTM. 